|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0034866,
umls-concept:C0034897,
umls-concept:C0036525,
umls-concept:C0205265,
umls-concept:C0205329,
umls-concept:C0376358,
umls-concept:C0458083,
umls-concept:C1273870,
umls-concept:C1515948,
umls-concept:C1522484,
umls-concept:C1555582
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2004-7-15
|
|
pubmed:abstractText |
To develop a clinical practice guideline for the management of men with metastatic, recurrent, or progressive carcinoma of the prostate. The focus of this document is on the use, combinations, and timing of various forms of androgen deprivation therapy (ADT) for the palliation of men with androgen-sensitive disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:American Society of Clinical Oncology,
pubmed-author:Ben-JosefEdgarE,
pubmed-author:BennettCharles LCL,
pubmed-author:LoblawD AndrewDA,
pubmed-author:MendelsonDavid SDS,
pubmed-author:MiddletonRichardR,
pubmed-author:PorterfieldHenryH,
pubmed-author:ScherHoward IHI,
pubmed-author:SharpStewart ASA,
pubmed-author:SmithThomas JTJ,
pubmed-author:SomerfieldMark RMR,
pubmed-author:TalcottJames AJA,
pubmed-author:TaplinMary EllenME,
pubmed-author:VirgoKatherine SKS,
pubmed-author:VogelzangNicholas JNJ,
pubmed-author:WadeJames LJLJr
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2927-41
|
|
pubmed:dateRevised |
2004-12-3
|
|
pubmed:meshHeading |
pubmed-meshheading:15184404-Antineoplastic Agents, Hormonal,
pubmed-meshheading:15184404-Combined Modality Therapy,
pubmed-meshheading:15184404-Disease Progression,
pubmed-meshheading:15184404-Humans,
pubmed-meshheading:15184404-Male,
pubmed-meshheading:15184404-Neoplasm Metastasis,
pubmed-meshheading:15184404-Neoplasm Recurrence, Local,
pubmed-meshheading:15184404-Palliative Care,
pubmed-meshheading:15184404-Prostatic Neoplasms,
pubmed-meshheading:15184404-Receptors, Androgen
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
|
|
pubmed:affiliation |
Cancer Policy and Clinical Affairs, 1900 Duke St, Suite 200, Alexandria, VA 22314, USA. guidelines@asco.org
|
|
pubmed:publicationType |
Journal Article,
Guideline,
Practice Guideline
|
